when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Gene Therapy (AAV) · news · pharmadog

← back to Gene Therapy (AAV)

News · Gene Therapy (AAV)

221 stories

24dSTAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDstat

25dSarepta names former AbbVie R&D exec Michael Severino as next CEObiospace

25dSarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEObiopharma dive

25dSTAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executivestat

25dLegend Biotech CEO abruptly steps down without permanent replacementfiercebiotech

25dFDA has recommitted to adcomms—but to what end?biospace

28dAmgen deploys patients to defend troubled Tavneos in FDA hearing requestbiospace

28dStudy of Yescarta patients reveals genetic red flags for CAR-T therapy side effectsfiercebiotech

28dScribe records upsized $129M IPO to bankroll lipid-lowering genetic medsfiercebiotech

29dArrowhead hits ‘best-case scenario’ with latest results for fat-lowering drugbiopharma dive

Jul 22, 26US ‘eroding’ lead in rare diseases a matter of national security: Reportbiospace

Jul 21, 26STAT+: Broad Institute, partners unveil new initiative to develop gene therapies for rare diseasesstat

Jul 21, 26STAT+: Anthropic deepens work with rare disease drugsstat

Jul 21, 26Dyne gets early 2027 decision date for Duchenne therapy, analysts expect ‘smooth’ reviewbiospace

Jul 21, 26STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilotsstat

Jul 20, 26‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kongfiercebiotech

Jul 20, 26STAT+: A most-wanted fugitive appears to have been secretly working as a biotech executivestat

Jul 20, 26Genetic medicine luminaries launch new center for personalized therapiesfiercebiotech

Jul 20, 26Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trialfiercebiotech

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 17, 26India’s life sciences sector at turning point for innovation: Reportbiospace

Jul 17, 26STAT+: The end for GSK’s chronic cough treatmentstat

Jul 17, 26FDA disavows Makary, Prasad’s papers as lawmaker blasts ‘shoot-from-the-hip’ policymakingbiospace

Jul 17, 26Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Miradorfiercebiotech

Jul 17, 26STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claimsstat

Jul 17, 26STAT+: MDCalc is scoring the clinical calculators used by millions of doctorsstat

Jul 17, 26Why affirming trans identities can be critical for suicide prevention counselingstat

Jul 17, 26Industry wants more clarity on NGS for assessing gene therapy safetyraps

Jul 16, 26‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsfiercebiotech

Jul 15, 26Nobel Laureate Jennifer Doudna enters AI protein design arenafiercebiotech

← prevpage 3 of 8next →